Eckert & Ziegler SE: Press Releases

23-12-2016

Eckert & Ziegler: New Executive Board member for Radiation Therapy. Harald Hasselmann succeeds Edgar Löffler.

03-11-2016

Eckert & Ziegler Q3/2016: Rise in Radiopharma segment income keeps the Group on track. Positive outlook for 2017.

18-10-2016

Eckert & Ziegler awards prizes to young nuclear medicine researchers

28-08-2016

Eckert & Ziegler buys Belgian provider of brachytherapy accessories

05-08-2016

Eckert & Ziegler takes over Brazilian Medical Transport Specialist – continues to expand presence in South America

02-08-2016

Eckert & Ziegler: Significant improvement in cost items in the first half year

02-06-2016

NETSPOT™ Gallium Ga 68 Dotatate Kit Approved By FDA Using The GalliaPharm® Ge-68/Ga-68 Generator As The Source Of Gallium-68

10-05-2016

Eckert & Ziegler: Sales Growth and Strong Operating Result in the First Quarter

25-04-2016

Eckert & Ziegler subscribes to capital increase at BEBIG

23-03-2016

Eckert & Ziegler 2015 annual financial statements: Sales growth of 10%. Profit increase of 58% thanks to extraordinary income.

21-03-2016 (Ad hoc press release)

Eckert & Ziegler: Record Income and Sales in 2015; Strong Rise in Net Liquidity. Hasselmann joins BEBIG Management Board

03-02-2016

Eckert & Ziegler expands cooperation program with drug developers in the field of nuclear medicine